Press Releases about Can-Fite Biopharma Ltd ADR
![](https://mms.businesswire.com/media/20230907395361/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230831472440/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230824833299/en/1874314/22/Lowe2.jpg)
![](https://mms.businesswire.com/media/20230818971170/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230717115155/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230707515823/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230629172102/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230613143878/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230602005005/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230601005125/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230530005167/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230515005115/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230509005292/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230502121010_can-fite-biopharma-spikes-on-pancreatic-cancer-inh.jpg)
![](https://mms.businesswire.com/media/20230502005336/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230424005284/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230410005137/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230330005099/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230316005101/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230313005284/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230214005420/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230124005187/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230111005589/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20230110005515/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20221230005205/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Can-Fite Announces ADS Ratio Change
December 30, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221228005179/en/1567498/22/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20221208005464/en/1567498/4/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
![](https://mms.businesswire.com/media/20221125005018/en/1567498/4/logo_-_sq_400x400_300dpi_%28002%29.jpg.jpg)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.